Insider filing · UTHR
Christopher Patusky
Director
profile →
United Therapeutics Corporation
UTHR · Healthcare · 372 filings in 24 months
ticker →
Christopher Patusky sold $1.8M of United Therapeutics (UTHR)
Executed Jan 10 2025, disclosed Jan 13 2025, 3 days later.
Value, as filed
$1.8M
4,891 sh across 5 lots
Executed
Jan 10 2025
the trade date, as filed
Disclosed
Jan 13 2025
3 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
CPChristopher Patusky (Director) filed 3 Form 4 reports in the trailing twelve months (0 purchases, 3 sales), most often in United Therapeutics Corporation (UTHR). The largest single filing was $1.7M of UTHR (2,910 sh × $569.00, as filed), executed Apr 24.
The name
UTHRHealthcare · United Therapeutics Corporation engages in the development and commercialization of products to address the unmet medical needs of patients…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→Other filings by Christopher Patusky in UTHR
UTHRSALE
United Therapeutics Corporation
$1.7M2,910 sh × $569.00
Exec Apr 24
Filed Apr 24 · 5:30 PM ET UTHRSALE United Therapeutics Corporation $579K
1,000 sh × $578.88
Exec Apr 17
Filed Apr 17 · 5:30 PM ET UTHRSALE United Therapeutics Corporation $496K
1,000 sh × $495.95
Exec Dec 15 2025
Filed Dec 16 2025 · 5:30 PM ET UTHRSALE United Therapeutics Corporation $1.4M
4,600 sh across 5 lots
Exec Mar 19 2025
Filed Mar 20 2025 · 5:30 PM ET